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S-layer (glyco)-proteins (SLPs) form a 
nanostructured envelope that covers the surface of 
different prokaryotes and show immunomodulatory 
activity. Previously, we have demonstrated that the 
S-layer glycoprotein from probiotic Lactobacillus 
kefiri CIDCA 8348 (SLP-8348) is recognized by 
Mincle (macrophage inducible C-type lectin 
receptor) and its adjuvanticity depends on the 
integrity of its glycans. However, the glycan´s 
structure has not been described so far. Herein, we 
analyze the glycosylation pattern of three SLPs, 
SLP-8348, SLP-8321, and SLP-5818, and explore 
how these patterns impacts their recognition by C-
type lectin receptors (CLRs) and the 
immunomodulatory effect of the L. kefiri SLPs on 
antigen-presenting cells. HPAEC-PAD performed 
after β-elimination showed glucose as the major 
component in the O-glycans of the three SLPs, 
however, some differences in the length of hexose 
chains were observed. No N-glycosylation signals 
were detected in SLP-8348 and SLP-8321, but SLP-
5818 was observed to have two sites carrying 
complex N-glycans based on a site-specific analysis 
and a glycomic workflow of the permethylated 
glycans. SLP-8348 was previously shown to 
enhance LPS-induced activation on both 
RAW264.7 macrophages and murine BMDCs; we 
now show SLP-8321 and SLP-5818 have a similar 
effect regardless of the differences in their 
glycosylation patterns. Studies performed with 
BMDCs from CLR-deficient mice revealed that the 
immunostimulatory activity of SLP-8321 depends 
on its recognition by Mincle, whereas SLP-5818’s 
effects are dependent on SignR3 (murine ortholog 
of human DC-SIGN). These findings encourage 
further investigation of both the potential 
application of these SLPs as new adjuvants and the 





Glycosylation is considered the most popular post-
translational modification targeting proteins. 
Despite until the mid 70´s it was assumed that the 
ability to glycosylate proteins was restricted to 
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eukaryotic cells and archaebacteria (1), nowadays it 
is known that this post-translational modification is 
not an exception in eubacteria, although it is early 
to predict the full extent of prokaryotic 
glycosylation (2). From the studies performed on 
eukaryotic cells, it is clear that the presence of 
glycans affect expression, localization and lifetime 
of numerous proteins thus affecting its functions as 
well as several downstream biological events (3).  
 
In eubacteria, protein glycosylation has been 
extensively studied in pathogens, emphasizing its 
relevance in virulence and pathogenicity. On the 
contrary, the nature and function of glycoproteins in 
non-pathogenic bacteria, including gut commensal 
species, remains largely unexplored (4). Since 
interactions between commensal bacteria, intestinal 
epithelial and immune cells play a crucial role in the 
maintenance of gut homeostasis, the study of 
protein glycosylation in gut commensal bacteria has 
become an expanding field of research due to the 
importance of the role of gut microbiota in health 
and disease (5, 6). This is particularly relevant in the 
case of surface proteins, which act as mediators of 
several interactions between microorganisms and 
their host.  
 
The S-layer is a nanostructured proteinaceous 
envelope constituted by subunits that self-assemble 
to form a two-dimensional lattice that covers the 
surface of different species of Bacteria and Archaea 
(7). Given their ubiquitous presence, S-layers are 
considered as the result of evolutionary changes of 
the microorganisms to survive in harsh 
environments (8) although there are no reports on 
common functions for all of them (9). The presence 
of S-layer has been found in both Gram-negative 
and Gram-positive bacteria, including pathogenic 
and non-pathogenic species (10). Regarding the 
members of the genus Lactobacillus, 
microorganisms commonly retrieved in the gut of 
different mammalian hosts as well as in fermented 
foods, the S-layer has been detected in many but not 
all species (11). Due to their unique self-assembly 
ability, presenting repetitive identical 
physicochemical properties down to the 
subnanometer scale, the S-layer proteins have gain 
interest in distinct areas of biotechnology, 
biomimetic and biomedicine. Indeed, different 
researchers have been conducted experiments 
focusing on the application of S-layer proteins for 
the development of new antigen/hapten carriers, 
adjuvants or vaccination vesicles (11, 12).  
 
After the presence of S-layer proteins in several 
strains of L. kefiri formerly isolated from kefir 
grains and characterized as potentially health-
promoting microorganisms was described (13), 
several studies have been performed in our 
laboratory to gain knowledge about structural and 
functional properties of these surface proteins. In 
particular, the S-layer proteins from L. kefiri strains 
show differences in their amino acid sequences, 
mainly in the C-terminal region of the polypeptide 
(14). Moreover, they are part of the small group of 
glycosylated S-layer proteins reported within the 
genus Lactobacillus (11), and until now, the 
detailed glycan structures have been described just 
for the strain L. kefiri CIDCA 83111 (15). 
 
Noteworthy, although the S-layer proteins were the 
first glycoproteins described in prokaryotes, the 
studies of the role of the glycan residues in the 
functional properties of these proteins are scarce 
and are usually focused on some archaea (16) or 
pathogenic bacteria (17,18). Regarding the genus 
Lactobacillus, there are some reports describing the 
involvement of the carbohydrate receptor DC-
specific ICAM-3-grabbing nonintegrin (DC-SIGN) 
in the functional activity of the S-layer proteins 
from L. acidophilus NCFM (19), L. plantarum (20) 
and L. kefiri JCM 5818 (21). In this sense, we have 
recently demonstrated that the S-layer glycoprotein 
from L. kefiri CIDCA 8348 is able to enhance the 
LPS-induced response in murine macrophages in a 
carbohydrate-receptor mediated process (22). 
Moreover, this SLP improves the OVA-specific cell 
immune response by triggering maturation of 
antigen presenting cells through the recognition of 
glycan moieties by Mincle (23). However, the 
structure of its glycans has not been determined so 
far. 
 
Considering all these evidences, in the present work 
we aim to determine the glycosylation patterns of 
the S-layer proteins expressed on different strains of 
L. kefiri and to analyze the impact on the 

















Glycan structures of L. kefiri S-layer proteins 
  
We have previously reported the composition and 
structure of the glycans present in the S-layer 
protein from L. kefiri CIDCA 83111 (15). In this 
work, glycosylation of the S-layer protein from L. 
kefiri JCM 5818, CIDCA 8348 and CIDCA 8321 
(SLP-5818, SLP-8348 and SLP-8321, respectively) 
were characterized. In this regard, the analysis of 




The SDS-PAGE bands corresponding to the 
purified SLPs of each strain were subjected to 
reductive β-elimination. Sugar composition was 
achieved by HPAEC-PAD. For this purpose, the 
released oligosaccharides were hydrolyzed, and 
monosaccharides were determined. In the three 
SLPs examined glucose was detected as the major 
component (Figure 1A, B and C). Also, in the three 
cases, when an alditol analysis was performed, 
sorbitol was detected. Taking into account that 
during the treatment the oligosaccharides linking 
the peptide are released and the reducing end of the 
oligosaccharides are reduced by NaBH4 to an 
alditol, the result indicates that a glucose unit is the 
linkage between the O-linked oligosaccharides and 
the peptides. (Figure 1D, E and F). 
 
The O-glycoproteomic analysis of the SLPs was 
performed by nanoHPLC-ESI-Orbitrap-HCD. An 
in-gel trypsin digestion of the purified glycoprotein 
from each strain was performed followed by a 
glycopeptide enrichment step using cotton HILIC 
chromatography. In SLP-5818, the analysis of the 
extracted ion chromatogram showed a defined 
region of O-glycosylation detected by EICs of 
oxonium ions where up to four hexose units were 
detected (m/z =163.06; 325.11, 487.16, 649.21). It 
is known that glycosidic bonds are more labile 
under the HCD dissociation than peptides. 
However, notably in this case, a high coverage level 
of peptide fragmentation was achieved by detecting 
b and y ions from the glycosylated peptide. 
Moreover, peptide-glycan fragments (Y ions) and 
the ion corresponding to the naked peptide were 
also detected (Figure 2A). Deconvolution of the 
ions allowed the attribution of the signals eluting at 
retention time between 10-14 min to peptide 
147SASASSASSASSAEQTTALTDAQK170 
carrying from 10 to 35 hexoses. Different 
glycoforms were resolved in the operating 
conditions of the RP nanoHPLC employed. It is 
clearly evidenced that the chromatographic elution 
of O-glycopeptides is based on the hydrophilic 
nature of the attached glycans, therefore on their 
decreasing size, from the largest to the smallest one.  
Interestingly, it was also possible to detect 
glycosylation from just one hexose unit co-eluting 
with the non-modified peptide (Figure 2B, Table 1), 
indicating that this O-glycosylation site is not fully 
occupied in this protein.  
 
On the other hand, it was interesting to detect in 
EICs from both, SLP-8321 and SLP-8348 a region 
where several clusters of ions with charge +4, +5, 
+6 and +7 corresponding to peptide 125-170 
containing the SASSASASA motif bearing up to 26 
hexose units (Figure 3A, B, Tables 2 and 3). 
MS/MS spectrum of the different ions showed b- 
and y- peptide fragments, confirming the peptide 
identification (Figure 3C, D). 
 
L. kefiri JCM 5818 N-glycome analysis  
 
Further on, taking into account that the S-layer 
protein of L. kefiri 83111 presented N-glycosylation 
(15) we searched for diagnostic oxonium ions for 
HexNAc+ (m/z 204.09, m/z 168.07 and m/z 138.05) 
in the MS/MS spectra. No signals were detected for 
SLP-8348 and SLP-8321, however SLP-5818 
evidenced the presence of the reporter ions. 
Therefore, we first tried an affinity-based 
purification of the SLP of L. kefiri JCM 5818 using 
immobilized Wheat Germ Agglutinin (WGA) to 
evidence this type of posttranslational modification. 
Interestingly, although whole protein fraction 
showed that the purification was not complete 
(Figure 4A, lane 2), the SDS-PAGE profile from the 
lectin-bound fraction showed a protein band with 
MW 67 kDa in accordance with the reported MW 
of the SLP-5818 (24,25) (Figure 4A, lane 1). This 
band was excised, trypsin-digested and subjected to 
mass spectrometry analysis confirming the S-layer 
protein identity and thus, the presence of N-
glycosylation in this protein (Supplemental 1 shows 
protein identification data). 
 
In order to determine the N-glycosylation sites in 
SLP-5818, we used PNGase F to release the N-












glycans. It is known that the glycosylated 
asparagine residue is converted to aspartic acid 
during the enzymatic reaction (26). As a result, a 
mass increase of 0.984 Da is obtained in the 
modified peptide. Based on this strategy, a sample 
of enriched glycopeptides from SLP-5818 was N-
deglycosylated using PNGase F and analyzed by 
nanoHPLC-ESI-Orbitrap. Due to the fact that 
spontaneous deamidation might occur, the ratio 
asparagine/aspartic acid was considered in order to 
avoid misassignments (Supplemental 2 shows 
peptide identification data). Thus, two N-
glycosylation sites at NVAVN55GTNALYTK and 
at DAALTSLN457NTVK were determined. As 
shown in Figure 4B, MS2 spectrum of peptide 
NVAVN55GTNALYTK showed fragment ion y9 
with a m/z = 982.48 (calc. m/z = 981.50,  0.984 
Da) confirming the N-glycosylation site at N55. In 
the same way, MS2 spectrum of peptide 
DAALTSLN457NTVK showed y5- fragment ion m/z 
= 576.30 (calc. m/z = 575.31,  0.984 Da) 
evidencing an N-glycosidic linkage in N457 (Figure 
4C). Further on, in order to determine the N-glycan 
structures attached to SLP-5818, we performed an 
enzymatic hydrolysis of the N-oligosaccharides 
using PNGase F. Glycans were separated, 
permethylated and analyzed by nanoHPLC-ESI-
Orbitrap.  The extracted ion chromatograms 
corresponding to m/z = 464.24 (HexNAc-Hex+), 
and m/z = 189.11 (dHex+) allowed to detect a family 
of complex permethylated N-glycans eluting 
between Rt 40-45 min (Figure 5A).  Main 
structures, m/z and mass errors are detailed in Table 
4. Figure 6 shows two examples of MS2 spectra of 
selected ions assigned to two bi-antennary glycans 
differing in the composition of one antennae. The 
permethylated N-glycans were also examined using 
MALDI-TOF MS and structures corresponding to 




Stimulation of murine macrophages by L kefiri 
SLPs 
 
Regarding that we have previously demonstrated 
that SLP-8348 can enhance LPS-induced activation 
of antigen presenting cells (22,23), we decided to 
test the ability of SLP-8321 and SLP-5818 to 
activate murine macrophage, using RAW 264.7 
cells as first model. As it was previously observed 
for SLP-8348 (22,23), the SLP-8321 and SLP-5818 
were not able to induce activation of RAW 264.7 
cells by themselves. However, respective 
significant increments in secreted IL-6 as well as in 
surface expression of CD40 and CD86 were 
observed for macrophages simultaneously exposed 
to E. coli LPS and L. kefiri S-layer glycoproteins in 
comparison to LPS-treated cells (Figure 7A, B). To 
note, no significant differences were observed 
among the stimulatory activity of strains despite the 
differences in their glycosylation patterns.  
 
Interaction of SLPs with different C-type lectin 
receptors 
 
Considering that it has been previously shown for 
SLP-8348 that the recognition of the glycan 
residues by a C-type lectin receptor (CLR) is a key 
event in the immunomodulatory activity of the 
protein (23), we decided to test the ability of SLP-
8321 and SLP-5818 to interact with different CLRs. 
As shown previously for SLP-8348 (23), SLP-8321 
and SLP-5818 bound to the CLRs DC-SIGN, 
SingR3, Langerin and Mincle (Figure 8A). As 
expected, a reduction of approximately 70% was 
observed in the SLP-CLR interactions in the 
presence of the Ca+2 chelating agent EGTA (Figure 
8B).   
 
Activation of BMDC by SLP-8321 and SLP-5818 
 
Regarding the ability of SLP-8321 and SLP-5818 to 
interact with different CLRs and considering that 
both glycoproteins enhanced LPS-induced response 
in murine macrophages, we decided to use BMDC 
from C57BL/6 mice as antigen presenting cells to 
assess both internalization of SLPs and cell 
activation. As shown for SLP-8348 (23), we 
observed that both SLP-8321 and SLP-5818 were 
internalized by BMDC in a dose-dependent way 
(Figure 9A). However, a significant decrease in the 
uptake of SLP-8321 was observed when BMDC 
from Mincle-/- mice were used. On the contrary, the 
internalization of SLP-5818 was only reduced in 
BMDC from SignR3-/- mice and was not affected by 
the absence of Mincle (Figure 9A).  
 
Following the same methodology previously 
reported (23), we decided to test the 
immunomodulatory activity of SLP-8321 and SLP-
5818 on BMDCs. Unlike in the case of RAW 264.7 












cells, both SLPs were able to induce the maturation 
of BMDC since a significant increment in the level 
of secreted IL-6 and TNF- as well as in the surface 
expression of CD40 and CD80 were observed 
(Figure 9B, C). The same effect was observed when 
BMDC were stimulated by a combination of SLPs 
and LPS. The stimulatory activity of SLP-8321 was 
lost when BMDC from Mincle-/- mice were used, 
whereas SLP-5818 was not able activate BMDC 
from SignR3-/- mice (Figure 9B, C).  
 
To further investigate the T-cell stimulatory 
function of the SLP-activated BMDCs, OVA-
treated BMDCs from wild type, Mincle-/-, SignR3-/- 
and CARD9-/- were incubated in the presence or 
absence of SLP-8321 or SLP-5818 with purified T 
cells from OT-II mice, as was previously performed 
with SLP-8348 (23). Both SLPs could enhance the 
OVA-specific T cell response since a higher IFN- 
secretion as well as higher CD4+T cell proliferation 
were observed upon simultaneous stimulation of 
wild type BMDCs with OVA and SLP-8321 or 
SLP-5818 compared to OVA-treated antigen 
presenting cells (Figure 10A,B). The absence of 
Mincle abrogated the immunostimulatory activity 
of SLP-8321 while SLP-5818 was not able to 
enhance CD4+T cell response when BMDCs from 
SignR3-/- mice were used (Figure 10A,B). As was 
expected, none of the SLPs assessed were able to 
potentiate CD4+T cell activation when assays were 
performed using BMDC from CARD9-/- mice, a 
downstream signaling protein of Mincle and 




Considering the ubiquitous presence of S-layer-
carrying microorganisms and the abundance of the 
S-layer proteins, it is evident that these structures 
reflect the evolutionary adaptation of the organisms 
to natural habitats and must have provided them 
with advantages in specific environmental and 
ecological conditions (8). Glycosylation is the post-
translational modification most frequently found in 
SLPs, a feature shared with other surface exposed 
proteins such as flagellin and pilin. Within the 
genus Lactobacillus, the glycoprotein nature of the 
S-layer proteins has been reported for strains of L. 
buchneri (28, 29), L. plantarum 41021/252 (28) L. 
acidophilus NCFM (19), L. acidophilus ATCC 
4356 (30), and several strains of L. kefiri (14,24). In 
this last species, we have previously described the 
composition and structure of the O- and N-glycans 
present in the SLP of the strain L. kefiri CIDCA 
83111 (15). Herein, we show that SLP-5818 also 
presents O- and N-glycosylated chains. In this case, 
peptide 147-170 is O-glycosylated in average with 
eight hexose units, but at difference with the SLP 
from L. kefiri CIDCA 83111, is not decorated with 
galacturonic acid (15). Regarding N-glycans, both 
SLP 5818 and SLP 83111 present two N-
glycosylation carrying bianntenary chains.  
On the other hand, SLP-8321 and SLP-8348 show 
100% of homology at primary sequence level (14) 
and despite they present six potential N-
glycosylation sites, no evidence of bearing N-
glycans was found. On the contrary, O-glycosidic 
chains constituted by 4 to 12 glucose units were 
detected in both SLPs.  
 
Inter-strain differences in the glycosylation patterns 
of SLP were also seen some years ago in 
Thermoanaerobacter thermohydrosulfuricus and 
Thermoanaerobacterium thermosaccharolyticum 
(31). Moreover, in Clostridium difficile the 
presence of a glycosylated SLP was only 
demonstrated in the strain Ox247 which encodes a 
putative glycosylation locus (18), while normally 
most C. difficile strains do not possess a 
glycosylated S-layer (32). On the other hand, 
Anzengruber and coworkers reported that SlpB 
from L. buchneri CD034, SlpN from L. buchneri 
NRRL B-30929 and L. buchneri SlpB from 
41021/251 showed identical O-glycans consisting 
of on average seven glucoses at four serine residues 
within the sequence S152-A-S154-S155-A-S157 without 
any evidence of the presence of N-glycosidic chains 
in those SLP (29). In this sense, SLP-8321 and SLP-
8348 show a higher similarity to the SLPs from L. 
buchneri strains than SLP-83111 and SLP-5818. 
Further studies are needed in order to elucidate the 
mechanisms through which the glycan chains are 
coupled to the peptide backbone in these surface 
proteins. 
 
As surface exposed structures, the SLPs could be a 
key mediator between bacteria and host immune 
system contributing to the shaping of the 
immunological response to pathogenic, commensal 
and probiotic microorganisms. By using murine 
macrophages RAW 264.7 cells as model, we have 
demonstrated that despite the differences between 












glycosylation patterns of SLP-8321 and SLP-5818, 
both proteins are able to enhance LPS-induced cell 
activation (Figure 7), similarly to previously 
demonstrated for SLP-8348 (22). These results 
suggest that O-glycans present in these three 
mentioned L. kefiri SLPs could be responsible, at 
least in part, of their immunostimulatory ability. 
 
On the other hand, as previously described with 
SLP-8348 (23), the assays using BMDCs from 
Mincle-/- and SignR3-/- mice allowed us to 
determine that the internalization of SLP-8321 and 
SLP-5818 as well as their ability to activate 
BMDCs were mainly mediated by Mincle and 
SignR3 (the murine ortholog of human DC-SIGN), 
respectively (Figure 9), which could be expected 
considering the differences in the glycosidic 
moieties present in those proteins. Moreover, the 
incubation of BMDCs with SLPs from different L. 
kefiri strains leading to the enhancement of 
activation of OVA-specific CD4+T cells from OT-
II mice, is also dependent of the presence of Mincle 
and SignR3 for SLP-8321 and SLP-5818, 
respectively (Figure 10). Some years ago, a 
pioneering work performed using a SlpA-knockout 
mutant L. acidophilus NFCM revealed that 
recognition of SlpA by DC-SIGN in presence of 
LPS induce an anti-inflammatory response in 
human monocyte-derived dendritic cells (19) 
suggesting the involvement of glycans in the 
immunomodulatory properties of SLPs. More 
recently, it was demonstrated that L. acidophilus 
NCK2187, a strain which solely expresses SlpA, 
and its purified SlpA binds to SignR3 to trigger 
regulatory signals that result in mitigation of 
experimental colitis, maintenance of healthy 
gastrointestinal microbiota, and mice protection 
(33). In addition, the ability of DC-SIGN to 
recognize the SLP-5818 was recently suggested by 
Prado Acosta and colleagues (21), which agrees 
with our findings. However, the role of glycan 
residues as well as the CLR involved in the 
internalization and immunostimulatory activity of 
the SLP-5818 had not been reported so far. On the 
contrary, is not surprising that Mincle, the CLR 
responsible for the recognition and adjuvanticity of 
the SLP-8348 (23), mediate the immunostimulatory 
effect of SLP-8321 on BMDCs since both 
glycoproteins present not only the same amino acid 
sequence (14) but also the same O-glycans. It is 
known that Mincle recognizes diverse sugar-
containing ligands including trehalose dimycolate 
glycolipid from mycobacteria, mannose-, glucose- 
or fucose-containing glycoconjugates, and Lewis 
antigen from Helicobacter pylori LPS (34). To 
note, it was recently reported that Mincle also 
recognize the O-linked oligosaccharides of the SLP 
from the Gram-negative oral pathogen Tannerella 
forsythia, and that interaction induces both pro- and 
anti-inflammatory cytokine secretion in 
macrophages (17). 
 
To resume, despite the differences in glycosylation 
patterns as well as the involvement of different 
CLRs, the glycosylated SLPs from distinct L. kefiri 
strains can induce activation of antigen presenting 
cells through the recognition of their glycans. Taken 
together, these findings encourage us to further 
investigate the potential application of these surface 
proteins derived from probiotic bacteria to the 
development of new adjuvants or carrier for vaccine 
antigens as well as to get deeper insight the protein 




Bacterial strains and culture conditions 
  
Lactobacillus kefiri CIDCA 8321, and 8348 
belonging to the collection of the Centro de 
Investigación y Desarrollo en Criotecnología de 
Alimentos (CIDCA) (35), and L. kefiri JCM 5818 
were used. Bacteria were cultured in deMan-
Rogosa-Sharpe (MRS)-broth (DIFCO, Detroit, 
USA) at 37°C for 48h, under aerobic conditions.  
 
S-layer protein extraction 
  
Extraction from bacterial cells at stationary phase 
was performed using 5M lithium chloride (LiCl) as 
described previously (22). The samples were 
centrifuged and the protein concentration in the 
supernatant was determined according to Bradford. 
The homogeneity of the protein extracts was tested 
by SDS-PAGE, stained with Coomassie blue (36). 
S-layer proteins were filtrated through a membrane 
of 0.22 µm pore diameter for cellular stimulation 
assays. 
 
Composition and structure of glycan moieties 
 












Lectin-based N-glycoprotein purification. The 
enrichment of glycoproteins was performed using 
Wheat Germ Agglutinin (WGA) lectin affinity 
chromatography. Briefly, 1 mL of WGA -
Sepharose (Sigma) was loaded onto a 5 mL column. 
Prior to sample purification, stationary phase was 
equilibrated with 20mM Tris pH 7.5, 0.5M NaCl, 
1mM CaCl2, 1mM MgCl2. Then, 50 L of protein 
sample was loaded using the latter buffer solution. 
Non-glycosylated proteins were washed using 
20mM Tris pH 7.5 containing 1M NaCl, 1mM 
CaCl2, 1mM MgCl2. Finally, the retained 
glycoproteins were eluted using the above buffer 
solution containing 0.5M N-Acetyl-D-
Glucosamine. The glycoprotein fraction was 
dialyzed against ultra-pure water using 
Spectra/Por® (Repligen) molecular porous 
membrane tubing cut-off 3.5 kDa. The lectin-based 
purification was monitored by SDS-PAGE and 
stained with Colloidal Coomassie Blue. 
 
Release of N-glycosidic chains by PNGase F 
treatment. The SDS-PAGE S-layer glycoprotein 
band was cut out from the gel, frozen for 3 h, and 
successively washed with (a) acetonitrile, (b) 20 
mM NaHCO3, pH 7, and (c) acetonitrile. The gel 
pieces were dried and the N-glycans were released 
by incubation with PNGase F (20 milliunits) (New 
England Biolabs Inc., Beverly, MA) overnight at 37 
°C in 20 mM NaHCO3, pH 7. The gel pieces were 
thoroughly washed, the supernatants were separated 
and filtered through an Ultrafree McFilter (Mr 
5000), dried, resuspended in 0.1% (v/v) formic acid 
(20 μL), and left at room temperature for 40 min. 
Finally, glycans were dried and suspended in water.  
 
Glycoprotein digestion. The protein band 
corresponding to the S-layer glycoproteins were cut 
out from the gel and washed with acetonitrile. The 
gel pieces were reduced with 10 mM DTT in 50 
mM NH4HCO3 at 55 °C for 30 min. They were 
further washed with acetonitrile and alkylated with 
55 mM IAA in 50 mM NH4HCO3 for 20 min at 
room temperature in darkness. After washing the 
gel pieces with 50 mM NH4HCO3 for 10 min and 
with acetonitrile for 5min, they were dried in a 
SpeedVac and submitted to digestion with 20 ng/μL 
trypsin (Sigma) in 40 mM NH4HCO3, 9 % 
acetonitrile at 37 °C overnight. Afterwards, the 
supernatants were separated and dried.  
 
In gel-reductive β-elimination and sugar analysis. 
O-linked glycans were released from each SDS-
PAGE band of the S-layer glycoproteins using 
0.05M NaOH / 1M NaBH4 and incubated overnight 
at 50°C. The solution was separated, acetic acid was 
added until pH 7 followed by repeated evaporation 
with methanol. The sample was dissolved in water, 
desalted in a Dowex 50 W (H+) (Fluka) column and 
dried in SpeedVac.  The β-eliminated samples were 
further hydrolyzed in 2 N TFA for 4 h at 100 °C. 
The acid was eliminated by evaporation and the 
hydrolysates were re-suspended in water for 
HPAEC-PAD (high performance anion exchange 
chromatography). Analysis was performed using a 
DX-500 Dionex BioLC system (Dionex Corp.). For 
neutral and amino sugars, a CarboPac PA20 with 
the corresponding guard column was used. Isocratic 
separations were achieved with 18mM NaOH and 
flow rate set to 0.4 mL/min. For alditols, a 
CarboPac MA 1 column was used with a 0.4 M 
NaOH isocratic program and a flow rate of 0.4 
mL/min.  
 
Permethylation of released oligosaccharides. After 
PNGase digestion, the oligosaccharides were 
methylated with NaOH in DMSO followed by 
addition of CH3I as described (37). 
 
Glycopeptide enrichment. Sample purification and 
glycopeptide enrichment was achieved by solid-
phase extraction Cotton-HILIC microtips as 
described (38). Briefly, HILIC microtips were 
equilibrated with three volumes of 85% ACN. 
Dried sample was resuspended in 85% acetonitrile. 
Prior to SPE clean-up step, sample was loaded onto 
the stationary phase by aspirating and dispensing 
the protein mixture. Peptides were washed off from 
the column with 85% ACN, 0.5% TFA, and the 
retained glycopeptides were eluted using water. The 
glycopeptide fraction was freeze-dried and stored at 
-20°C until mass spectrometry analysis.  
 
Mass spectrometry analysis. The enriched 
glycopeptide mixtures were re-suspended in 50% 
acetonitrile -1% formic acid/water 1:1. The digests 
were analyzed in a nanoLC 1000 coupled to an 
EASY-Spray Q Exactive Mass Spectrometer 
(Thermo Scientific) with a HCD (High Collision 
Dissociation) and an Orbitrap analyzer. An Easy 
Spray PepMap RSLC C18 column (50 μm × 150 
mm, particle size 2.0 μm, pore size: 100 Å) at 40 °C 












was used. Separation was achieved with a linear 
gradient from 5% to 35% solvent B developed in 75 
min, at a flow of 300 nL/min (mobile phase A: 
water-0.1% formic acid; mobile phase B: 
acetonitrile-0.1% formic acid). Injection volume 2 
μL. Spray voltage (+): 3.5 kV; (−): 3.0 kV. A full-
scan survey MS experiment (m/z range from 400 to 
2000; automatic gain control target 3 106; 
maximum IT: 200 ms, resolution at 400 m/z: 70000. 
Data Dependent MS2 method was set to the 
centroid mode, resolution 17500; maximum IT 
50ms; automatic gain control target 105; fragment 
the top 15 peaks in each cycle; NCE: 27. 
For the analysis of permethylated oligosaccharides 
HPLC separation was achieved with a linear 
gradient of solvent B from 5% to 60% developed in 
75 min, flow: 300 nL/min (solvent A: water-0.1% 
formic acid; solvent B: ACN-0.1% formic acid). 
Injection volume: 5 μL. 
 
MALDI-TOF MS (matrix-assisted laser 
desorption/ionization time-of-flight mass 
spectrometry analysis).  Measurements were 
performed using an Ultraflex II TOF/TOF mass 
spectrometer (Bruker Daltonics GmbH, Bremen, 
Germany) equipped with a solid-state laser (λ = 355 
nm). The system was operated by the Flexcontrol 
3.3 package (Bruker Daltonics GmbsH, Bremen, 
Germany) using gentisic acid as matrix. 
 
Data Analysis. Proteome Discoverer 2.1 (Thermo 
Scientific) assisted protein identification. The mass 
tolerances for MS and MS/MS were 10 ppm and 
0.02 Da respectively. Missed cleavages allowed for 
tryptic digestion was 1. Carbamidomethylation of 
cysteine residues was set as static modification and 
oxidation of methionine as dynamic modification. 
For N-glycosite analysis conversion of asparagine 
to aspartic acid was included as dynamic 
modification. Precursor mass tolerance was 10 
ppm, and fragment mass tolerance was 20 ppm. 
Confident identification for peptides was set to a 
score > 100.  
Glycopeptide search was performed with 
MaxQuant version 1.6.5, Byonic™ from 
ProteinMetrics, Proteome Discoverer 2.2 and 
using a semi-automatic home-made software. 
(A0A1C3S3I4 S-layer protein OS=Lactobacillus 
kefiri OX=33962 GN=S-layer A0A1C3S3T6 S-
layer protein OS=Lactobacillus kefiri OX=33962 
GN=S-layer.  
All glycopeptides identifications from both 
searches were manually curated.  MS-Convert Tool 
(from ProteoWizard platform tools) converted raw 
data from enriched glycopeptides into text files for 
manual annotation. Deconvolution was assisted by 
Xtract on Thermo Xcalibur 3.0.63.  
 
C-type Lectin Receptor recognition of S-layer 
proteins 
  
The CLR-reactivity on S-layer proteins from L. 
kefiri CIDCA 8321 (SLP-8321) and L. kefiri JCM 
5818 (SLP-5818) was evaluated by an ELISA type 
assay as described previously (23,39). A half-area 
microplate (Greiner Bio-One GmbH, 
Frickenhausen, Germany) was coated with 0.25 µg 
of SLP per well for 16 h at 4ºC and blocked with 
1%BSA (Thermo Fisher Scientific, Darmstadt, 
Germany) for 2 h at room temperature (RT). Then, 
0.25 µg of each CLR-hFc fusion protein in lectin-
binding buffer (50 mM HEPES, 5 mM MgCl2, and 
5 mM CaCl2) was added and incubated for 1 h at 
RT. For inhibition assays, CLR-hFc fusion proteins 
were pre-incubated with 5mM of EGTA (Sigma-
Aldrich, USA). After washes, HRP-conjugated 
anti-human IgG anti-body (Dianova) was added to 
each well for 1 h at RT. Finally, plates were 
incubated with chromogenic substrate (o-
phenylenediamine dihydrochloride substrate tablet 
(Thermo Fisher Scientific), 24 mM citrate buffer, 
0.04% H2O2, 50 mM phosphate buffer in H2O). The 
reaction was stopped with 2.0 M sulfuric acid and 
the product was read at 495 nm using a Multiskan 





The source of the CLR- and CARD9-deficient mice 
was described previously (40,41,42). Mincle−/−, 
SignR3−/− and CARD9−/− mice were backcrossed on 
C57BL/6 background over ten generations in the 
animal facility of the Federal Institute for Risk 
Assessment (Berlin, Germany). All mouse lines 
(including wild-type and C57BL/6-Tg 
(TcraTcrb)425Cbn/J (OT-II) mice) were kept in the 
animal house of the University of Veterinary 
Medicine (Hannover, Germany) with water and 
food supplied ad libitum. Mice were sacrificed for 
the isolation of spleen cells (OT-II transgenic mice) 












or the preparation of bone marrow for BMDC 
generation (Mincle−/−, CARD9−/−, SignR3−/−, and 
WT mice). Sacrificing of mice for scientific 
purposes was approved by the Animal Welfare 
Officers of the University of Veterinary Medicine 




The monocyte/macrophage murine cell line RAW 
264.7 was cultured in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with: 10% (v/v) 
heat-inactivated (30 min/60◦C) fetal bovine 
serum(FBS), 1% (v/v) non-essential amino acids 
and 1% (v/v) penicillin-streptomycin solution (100 
U/mL penicillin G, 100 g/mL streptomycin). All 
cell culture reagents were from GIBCO BRL Life 
Technologies (Rockville, MD, USA). 
Bone marrow-derived dendritic cells (BMDCs) 
were generated from C57BL/6 wild type, Mincle 
−/−, CARD9−/− or SignR3 −/− bone marrow precursors 
(2.5 × 105 cells/ml) that were plated in complete 
culture medium (IMDM supplemented with 2mM 
glutamine, 10% (v/v) FBS, 100 U/ml penicillin and 
100μg/ml streptomycin) supplemented with a GM-
CSF containing supernatant fromP3-X63 cells. 
Medium was exchanged every 48 h and BMDCs 
were used after 8–10 days of differentiation to 
ascertain that ≥80% of the cell population expressed 
the marker CD11c (43). 
 
Cells stimulation assays  
 
These experiments were performed as previously 
described (22,23). RAW 264.7 cells (2.5 × 105) 
were distributed onto 24-well microplates (JET 
BIOFIL®, China), and the medium volume was 
adjusted to 0.5mL. The plates were incubated for 48 
h at 37◦C in a 5% CO2 95% air atmosphere to allow 
cell adherence prior to experimentation. After that, 
cells were treated with SLP-8321 or SLP-5818 
(10μg/mL), in the presence or absence of LPS 
0.1μg/mL (LPS from Escherichia coli O111:B4, 
SIGMA, USA), in DMEM for 24 h at 37ºC in a 5% 
CO2 95% air atmosphere. Cells were incubated with 
anti-CD40 (3/23), anti-CD86 (P03.1) and then 
analyzed by flow cytometry.  
BMDCs from wild type or CLR-deficient mice (1 × 
105 cells/well) were distributed onto 96-well 
microplates (Sarstedt, Germany) and stimulated 
with SLP-8321 or SLP-5818 (10μg/mL), LPS 
(0.25μg/mL) or the combination of both for 16 h at 
37ºC in a 5%CO2 95%air atmosphere. Culture 
supernatants were collected and analyzed by ELISA 
for IL-6 and TNF- secretion. Cells were incubated 
with anti-CD16/32 (93) to block cell surface 
FcgRII/RIII receptors, stained with anti-CD11c 
(N418), CD40 (3/23), CD80 (16-10A1) and then 
analyzed by flow cytometry. 
 
BMDCs/T cell co-culture assay  
 
Splenocytes were isolated from OT-II transgenic 
mice by flushing the spleen with complete IMDM 
medium. After erythrocyte lysis, cells were 
resuspended in MACS buffer (0.5% BSA, 2 mM 
EDTA in PBS). T cells were obtained by magnetic-
activated cell separation (MACS) using Pan T cell 
isolation kit II, mouse (Miltenyi Biotech, Bergisch 
Gladbach, Germany) according to the 
manufacturer's instructions. T cells were labelled 
with CFSE (carboxyfluorescein diacetate 
succinimidyl ester, Sigma-Aldrich,USA) and 
seeded on a 96-well round bottom culture plate 
(7x104 cells/well). After 30 minutes, BMDCs 
treated with OVA (Endo Grade® Ovalbumin, 
LIONEX GmbH, Germany) or OVA/SLPs were 
added and incubated for 72 h. Culture supernatants 
were collected for IFN-γ secretion. Proliferation 
index of CD4+ T cells within each experimental 
group was calculated as the ratio between the 
percentage of CFSElow CD4+ cells and CFSElow 
CD4+ cells from OVA-treated BMDCs. 
 
Cytokine quantification in culture supernatants  
 
Production of IL-6 by macrophages was analyzed 
by ELISA from BD-Pharmingen (San Diego, 
USA). Secretion of IL-6 and TNF-α by BMDCs and 
IFN-γ from purified T cells were analyzed by 
ELISA from PeproTech (USA). The assays were 
performed according to the manufacturer's 
instructions. After determining optical densities, 
cytokine levels in cell culture supernatants were 
calculated using the GraphPad Prism 7.0 program. 
 
Immunocytostaining and flow cytometry 
 
After stimulation experiments, cells were washed 
twice with PBS containing 2% (v/v) FBS and then 
labelled with specific monoclonal antibodies for 
30min at 4◦C. Cells were washed twice and then 












fixed with 1% (v/v) formaldehyde. Cells were 
analyzed using a FACSCalibur Analyzer (BD 
Biosciences) or Attune NxT Flow Cytometer 
(Thermo Fisher Scientific). Data analysis was 
performed using the FlowJo Software (FlowJo, 
Ashland, OR, USA). 
 
Statistical analysis  
 
Values from at least three independent experiments 
were analyzed by using a one-way or two-way 
ANOVA with Tukey’s post hoc test (P<0.05 was 
considered statistically significant). Statistical 
analysis was performed with the GraphPad Prism 
program (GraphPad Software, San Diego, 
California, USA). 
 
Data availability: The mass spectrometry 
proteomics data have been deposited to the 
ProteomeXchange Consortium via the PRIDE [44] 
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Figure 1. Analysis by HPAEC-PAD of the sugar components of the O-glycosidic chains released by 
reductive β-elimination. A, B and C, neutral monosaccharides released from SLP-5818, SLP-8348 and 
SLP-8321 respectively. D, E and F, alditols released from SLP-5818, SLP-8348 and SLP-8321 






Figure 2. O-glycopeptide analysis by nanoHPLC-ESI-Orbitrap of SLP-5818. A, Selected MS2 spectra, 
m/z 1537.8352. (y and b peptide fragments and Y glycan-peptide fragments are indicated). B, Full MS 
spectrum at retention time 19.89 min showing signals corresponding to 147-170 unmodified peptide and to 
the same peptide bearing one or two hexose units. 
Figure 3. O-glycopeptide analysis. A, B, Full MS spectra of SLP-8348 and SLP-8321 respectively, 
showing glycopeptide families with charge +4, +5, +6 and +7. C, MS/MS spectra of ion m/z 1119, 8097
+6
 
from SLP-8348. D, MS/MS spectra of ion m/z 1597.6873
+4
 from SLP-8321 (y and b peptide fragments and 
hexose fragments are indicated). 
Figure 4. N-Glycosylation analysis of SLP-5818. A, WGA-Sepharose analysis: lane 1: Lectin bound 
glycoprotein, lane 2: SLP extract, lane 3: MW markers. MS2 spectra of enzymatically deglycosylated 
peptides: B, peptide 51-63 and C, peptide 450-461, containing the 0.9846 Da mass increase derived from 
Asn/Asp conversion. Differences between the in silico digested peptides (b and y ions in the inset) and the 
experimental masses are highlighted in blue. 
Figure 5. A, NanoHPLC-ESI-Orbitrap analysis of permethylated N-glycans. a) Total ion current 
chromatogram. Extracted ion chromatograms of permethylated oxonium ions: b) m/z 464.24 (Hex-HexNAc 
oxonium ion); c) m/z 189.11 (dHex
 
oxonium ion).      dHex;     ,      Hex;      HexNAc. B, MALDI-TOF MS 
spectrum of permethylated N-glycans. 
Figure 6. Selected MS2 spectra of permethylated N-glycans detected by nanoHPLC-ESI-Orbitrap 
analysis. A, m/z 1009.5226. B, m/z 886.9614.     dHex;     ,     Hex;     HexNAc. 
Figure 7. Modulation of LPS-induced maturation of macrophages by L. kefiri SLP-8321 and SLP-
5818. A, IL-6 concentration (pg/mL) by capture ELISA in the supernatant of the murine RAW 264.7 
cultures after 24 h of stimulation. B, Percentage of CD40+ and CD86+ RAW 264.7 cells after 24 h of 
stimulation. A representative figure of three independent experiments is shown (±SD, indicated by error 
bars). *P< 0.05; n.s: not significant. 
Figure 8. C-type Lectin Receptor recognition of SLP-8321 and SLP-5818. A, Reactivity of CLR-hFc 
fusion proteins on SLP was evaluated by an ELISA type assay (using the same experimental model as in 
Ref. 23). B, Inhibition assays were performed using EGTA, a Ca2+ chelating agent. These are representative 
figures of three independent experiments (±SD, indicated by error bars). 
Figure 9. SLP-8321 and SLP-5818 are recognized by specific CLRs expressed on BMDCs. A, Binding 
(4°C, squares) and internalization (37°C, circles) of Atto 647N-labeled-SLP at different concentrations on 
CD11c+ cells from C57BL/6 and CLR-deficient mice. B, Level of IL-6 and TNF- in culture supernatant 
of BMDCs from C57BL/6 and CLR-deficient mice after stimulation with SLPs, LPS or the combination of 
both for 24h. C, Cell surface expression of CD40 and CD86 on CD11c+ cells from C57BL/6 and CLR-
deficient mice after stimulation with SLPs, LPS or the combination of both for 24h. A representative figure 
of three independent experiments is shown, following the same experimental lines described in Ref. 23 
(±SD, indicated by error bars). *P<0.05; n.s: not significant; KO: knock-out. 












Figure 10. CLR-SLP specific interactions impact on T-cell stimulatory function of the SLP-activated 
BMDCs. Cells from C57BL/6 and CLR-deficient mice were stimulated with SLP, OVA or the combination 
of both for 24h and then exposed to CFSE-labelled CD4+ T cells from OT-II mice using the same 
experimental model as in Ref. 23. A, IFN- level in supernatants measured after five days. B, Proliferation 
index of CD4+ T cells. A representative figure of three independent experiments is shown (±SD, indicated 
by error bars). *P<0.05; n.s: not significant; KO: knock-out. 
 
  

















Peptide Glycoform m/z M+3 (calc.) m/z M+3 (exp.) error (ppm) 
1472256.0353170 
Hex1 807.0367 807.0370 -0.41 
Hex2 861.0543 861.0551 -0.97 
Hex3 915.0719 915.0724 -0.58 
Hex4 969.0895 969.0895 -0.03 
Hex5 1023.1071 1023.1075 -0.42 
Hex6 1077.1247 1077.1252 -0.50 
Hex7 1131.1423 1131.1429 -0.56 
Hex8 1185.1599 1185.1581 1.49 
Hex9 1239.1775 1239.1770 0.38 
Hex10 1293.1951 1293.1959 -0.64 
Hex11 1347.2127 1347.2139 -0.92 
Hex12 1401.2303 1401.2311 -0.59 
Hex13 1455.2479 1455.2474 0.32 
Hex14 1509.2655 1509.2646 0.57 
Hex15 1563.2831 1563.2825 0.36 
Hex16 1617.3007 1617.3018 -0.70 
Hex17 1671.3183 1671.3114 4.11 
Hex18 1725.3359 1725.3359 -0.02 
Hex19 1779.3535 1779.3544 -0.52 
Hex20 1833.3711 1833.3687 1.29 
Hex21 1887.3887 1887.3909 -1.18 
Hex22 1941.4063 1941.4103 -2.08 
Hex23 1995.4239 1995.4330 -4.58 









































Peptide Glycoform m/z M+4 (calc.) m/z M+4 (exp.) error (ppm) 
1254277.0207170 
hex22 1961.5529 1961.5544 -0.78 
hex21 1921.0397 1921.0396 0.04 
hex20 1880.5265 1880.5272 -0.39 
hex19 1840.0133 1840.0141 -0.45 
hex18 1799.5001 1799.5057 -3.13 
hex17 1758.9869 1758.9868 0.04 
hex16 1718.4737 1718.4769 -1.88 
hex15 1677.9605 1677.9602 0.16 
hex14 1637.4473 1637.4468 0.29 
hex13 1596.9341 1596.9348 -0.45 
hex12 1556.4209 1556.4201 0.50 
hex11 1515.9077 1515.9086 -0.61 
hex10 1475.3945 1475.3951 -0.42 
hex9 1434.8813 1434.8822 -0.64 
hex8 1394.3681 1394.3696 -1.09 
hex7 1353.8549 1353.8557 -0.61 
hex6 1313.3417 1313.3422 -0.40 





















hex22 1961.5529 1961.5525 0.19 
hex21 1921.0397 1921.0369 1.44 
hex20 1880.5265 1880.5252 0.68 
hex19 1840.0133 1840.0122 0.58 
hex18 1799.5001 1799.5038 -2.07 
hex17 1758.9869 1758.9854 0.84 
hex16 1718.4737 1718.4721 0.92 
hex15 1677.9605 1677.9615 -0.61 
hex14 1637.4473 1637.4498 -1.54 
hex13 1596.9341 1596.9349 -0.52 
hex12 1556.4209 1556.4187 1.40 
hex11 1515.9077 1515.9091 -0.94 
hex10 1475.3945 1475.3958 -0.90 
hex9 1434.8813 1434.8829 -1.13 
hex8 1394.3681 1394.3687 -0.45 
hex7 1353.8549 1353.8516 2.42 
hex6 1313.3417 1313.3427 -0.78 
Hex5 1272.8285 1272.8290 -0.41 
























HexNAc4-Hex5-dHex 1111.5749 1111.5746 0.3 
HexNAc4-Hex4-dHex 1009.525 1009.5243 0.7 
HexNAc3-Hex4-dHex 886.96185 886.962 0.2 
HexNAc4-Hex3-dHex 907.4751 907.4769 2.0 
HexNAc4-Hex5 1024.5303 1024.5303 0.0 
HexNAc4-Hex4 922.4804 922.4775 3.1 
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GCc35_Positivo #3749 RT: 19.89 AV: 1 NL: 1.44E6
T: FTMS + p NSI Full lock ms [400.0000-2000.0000]































































GCc35_Positivo #3749 RT: 19.89 AV: 1 NL: 1.44E6
T: FTMS + p NSI Full lock ms [400.0000-2000.0000]































































GCc35_Positivo #2592 RT: 14.40 AV: 1 NL: 4.98E5
T: FTMS + c NSI d Full ms2 1537.8352@hcd27.00 [100.0000-6000.0000]





















































































GCD35 #8175 RT: 38.72 AV: 1 NL: 2.05E7
T: FTMS + p NSI Full lock ms [400.0000-2000.0000]





















































GCB35 #7866 RT: 38.65 AV: 1 NL: 1.27E6
T: FTMS + p NSI Full lock ms [400.0000-2000.0000]
































































GCD35 #8568 RT: 40.27 AV: 1 NL: 1.90E4
T: FTMS + c NSI d Full ms2 1119.8097@hcd27.00 [100.0000-6000.0000]




























































GCB35 #8123 RT: 39.71 AV: 1 NL: 2.18E4
T: FTMS + c NSI d Full ms2 1597.6873@hcd27.00 [100.0000-6000.0000]








































































GC_CN #7586 RT: 31.11 AV: 1 NL: 2.86E4
T: FTMS + c NSI d Full ms2 683.3548@hcd30.00 [120.0000-1415.0000]




















































calc. m/z b-ion residue y-ion calc. m/z
--- 1 N 13 ---
214.12 2 V 12 1250.67
285.16 3 A 11 1151.61
384.22 4 V 10 1080.57
498.27 5 N 9 981.50
555.29 6 G 8 867.46
656.34 7 T 7 810.44
770.38 8 N 6 709.39
841.42 9 A 5 595.35
954.50 10 L 4 524.31
1117.56 11 Y 3 411.22
1218.61 12 T 2 248.16
--- 13 K 1 147.11
GC_CN #8147 RT: 32.94 AV: 1 NL: 7.65E4
T: FTMS + c NSI d Full ms2 624.3284@hcd30.00 [120.0000-1295.0000]






























































calc. m/z b-ion residue y-ion calc. m/z
--- 1 D 12 ---
187.07 2 A 11 1131.64
258.11 3 A 10 1060.60
371.19 4 L 9 989.56
472.24 5 T 8 876.48
559.27 6 S 7 775.43
672.36 7 L 6 688.40
786.40 8 N 5 575.31
900.44 9 N 4 461.27
1001.49 10 T 3 347.23
1100.56 11 V 2 246.18
--- 12 K 1 147.11
Δmass = 0.9846 Da
Δmass = 0.9846 Da
GC_CN #7586 RT: 31.11 AV: 1 NL: 2.86E4
T: FTMS + c NSI d Full ms2 683.3548@hcd30.00 [120.0000-1415.0000]




















































calc. m/z b-ion residue y-ion calc. m/z
--- 1 N 13 ---
214.1 2 V 2 1250.67
285.16 3 A 11 1151.61
384.22 4 V 10 1080.57
498.27 5 N 9 981.50
555.29 6 G 8 867.46
656.34 7 T 7 810.44
770.38 8 N 6 709.39
841.42 9 A 5 595.35
954.50 10 L 4 524.31
1117.56 11 Y 3 411.22
1218.61 12 T 2 248.16
--- 13 K 1 147.11
GC_CN #8147 RT: 32.94 AV: 1 NL: 7.65E4
T: FTMS + c NSI d Full ms2 624.3284@hcd30.00 [120.0000-1295.0000]






























































calc. m/z b-ion residue y-ion calc. m/z
--- 1 D 12 ---
187.07 2 A 11 1131.64
258.11 3 A 10 1060.60
371.19 4 L 9 989.56
472.24 5 T 8 876.48
559.27 6 S 7 775.43
672.36 7 L 6 688.40
786.40 8 N 5 575.31
900.44 9 N 4 461.27
1001.49 10 T 3 347.23
1100.56 11 V 2 246.18
--- 12 K 1 147.11
Δmass = 0.9846 Da
Δmass = .9846 Da
GC_CN #7586 RT: 31.11 AV: 1 NL: 2.86E4
T: FTMS + c NSI d Full ms2 683.3548@hcd30.00 [120.0000-1415.0000]




















































calc. m/z b-ion residue y-ion calc. m/z
--- 1 N 13 --
214.12 2 V 12 1250.67
285.16 3 A 1 151.61
384.22 4 V 10 1080.57
498.27 5 N 9 981.50
555.29 6 G 8 867.46
656.34 7 T 7 810.44
770.38 8 N 6 709.39
841.42 9 A 5 595.35
954.50 10 L 4 524.31
1117.56 11 Y 3 411.22
1218.61 12 T 2 248.1
--- 13 K 1 147.11
GC_CN #8147 RT: 32.94 AV: 1 NL: 7.65E4
T: FTMS + c NSI d Full ms2 624.3284@hcd30.00 [120.0000-1295.0000]






























































calc. m/z b-ion residue y-ion calc. m/z
--- 1 D 12 ---
187.07 2 A 11 1131.64
258.11 3 A 10 1060.60
371.19 4 L 9 989.56
472.24 5 T 8 876.48
559.27 6 S 7 77 .43
672.36 7 L 6 688.40
786.40 8 N 5 5 5.31
900.44 9 N 4 461.27
1001.49 10 T 3 347.23
1100.56 11 V 2 246.18
--- 12 K 1 147.11
Δmass = 0.9846 Da
Δmass = 0.9846 Da
GC_CN #7586 RT: 31.11 AV: 1 NL: 2.86E4
T: FTMS + c NSI d Full ms2 683.3548@hcd30.00 [120.0000-1415.0000]




















































calc. m/z b-ion residue y-ion calc. m/z
--- 1 N 13 ---
214.12 2 V 12 1250.67
285.16 3 A 11 1151.61
384.22 4 V 10 1080.57
498.27 5 N 9 981.50
555.29 6 G 8 867.46
656.34 7 T 7 810.44
770.38 8 N 6 709.39
841.42 9 A 5 595.35
954.50 10 L 4 524.31
1117.56 11 Y 3 411.22
1218.61 12 T 2 248.16
- - 13 K 1 147.11
GC_CN #8147 RT: 32.94 AV: 1 NL: 7.65E4
T: FTMS + c NSI d Full ms2 624.3284@hcd30.00 [120.0000-1295.0000]






























































calc. m/z b-ion residue y-ion calc. m/z
--- 1 D 12 ---
187.07 2 A 11 1131.64
258.11 3 A 10 1060.60
371.19 4 L 9 989.56
472.24 5 T 8 876.48
559.27 6 S 7 775.43
672.36 7 L 6 688.40
786.40 N 5 575.31
900.44 9 N 4 461.27
1001.49 10 T 3 347.23
1100.56 11 V 2 246.18
--- 12 K 1 147.11
Δmass = 0.9846 Da
Δmass = 0.9846 Da
A B
C















RT: 0.00 - 75.01




























m/z= 100.00-6000.00 F: 
FTMS + p NSI Full ms 
[400.0000-2000.0000]  MS 
GC5818_NGlicano
NL: 2.03E6
m/z= 464.24-464.25 F: 
ms2   MS 
GC5818_NGlicano
NL: 1.03E4
m/z= 362.17-362.18 F: 
ms2   MS 
GC5818_NGlicano
NL: 8.72E3
m/z= 189.10-189.11 F: 
ms2   MS 
GC5818_NGlicano
RT: 0.00 - 75.01























m/z= 100.00-6000.00 F: 
FTMS + p NSI Full ms 
[400.0000-2000.0000]  MS 
GC5818_NGlicano
L: 2.03E6
/z= 464.24-464.25 F: 
ms2   MS 
GC5818_NGlicano
: 1. 4
/  3 2.17-3 2.18 : 
    
li
L: 8.72 3
/z  189.10-189.11 : 
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Figure 5.










GC5818_NGlicano #9384 RT: 43.67 AV: 1 NL: 7.53E4
F: FTMS + c NSI d Full ms2 1009.5091@hcd27.00 [100.0000-2080.0000]
































































































































































GC5818_NGlicano #8087 RT: 37.97 AV: 1 NL: 3.38E5
F: FTMS + c NSI d Full ms2 886.9514@hcd27.00 [100.0000-1830.0000]

















































m/z calc : 886.9618
Figure 6.































































































Mincle SignR3 hDC-SIGN MGL-1 hFc-emptyLangerin
A
B
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